Page 31 - ARNM-2-1

Advances in Radiotherapy
& Nuclear Medicine Is 5-mm PTV margin 4D-CT-based radiotherapy

doi: 10.1118/1.4740170 Therapy (SABR): A Resource. United Kingdom: SABR UK
30. Jasper K, Liu B, Olson R, Matthews Q. Evidence-based Consortium; 2014.
planning target volume margin reduction for modern lung 34. Yamamoto T, Langner U, Loo BW Jr., Shen J, Keall PJ.
stereotactic ablative radiation therapy using deformable Retrospective analysis of artifacts in four-dimensional CT
registration. Adv Radiat Oncol. 2021;6(6):100750. images of 50 abdominal and thoracic radiotherapy patients.
doi: 10.1016/j.adro.2021.100750 Int J Radiat Oncol Biol Phys. 2008;72(4):1250-1258.
31. Liang Z, Yang J, Liu H, et al. Real-time tumor motion doi: 10.1016/j.ijrobp.2008.06.1937
monitoring and PTV margin determination in lung SBRT 35. Sentker T, Schmidt V, Ozga AK, et al. 4D CT image artifacts
treatment. Acta Oncol. 2019;58(12):1786-1789. affect local control in SBRT of lung and liver metastases.
doi: 10.1080/0284186X.2019.1648862 Radiother Oncol. 2020;148:229-234.
32. Murray L, Ramasamy S, Lilley J, et al. Stereotactic ablative doi: 10.1016/j.radonc.2020.04.006
radiotherapy (SABR) in patients with medically inoperable 36. Jiang SB, Wolfgang J, Mageras GS. Quality assurance
peripheral early stage lung cancer: Outcomes for the first UK challenges for motion-adaptive radiation therapy: Gating,
SABR cohort. Clin Oncol (R Coll Radiol). 2016;28(1):4-12. breath holding, and four-dimensional computed tomography.
doi: 10.1016/j.clon.2015.09.007 Int J Radiat Oncol Biol Phys. 2008;71(1 Suppl):S103-S107.
33. SABR UK Consortium. Stereotactic Ablative Body Radiation doi: 10.1016/j.ijrobp.2007.07.2386

Volume 2 Issue 1 (2024) 10 https://doi.org/10.36922/arnm.2784